Alligator Bioscience has secured additional subscription and top guarantee commitments for its SEK12...
SyntheticMR redovisade ett svagt tredje kvartal där omsättningen sjönk med 7 procent och resultatet ...
* Rail and Kvalitetsbygg sold, while we see... * ..
Redeye retains its positive take on Formpipe following the finalisation of the Public divestment and...
* Public divestment completed (EV SEK 850m)... * ..
Redeye provides an update following Mindark’s Q3 2025 report.
Will lower financial expenses by SEK 2m per year We estimate ND/EBITDA of ~1.
Redeye provides an update on Saniona. In Q3, Saniona expectedly received the USD42.
Redeye comments on the USTR’s confirmation that the Section 301 tariff exemption for computer cases ...
* An organic decline of 3% in Q3 * We cut sales estimates by 4-2% for '26e-'27e * Positioned for a m...
Redeye comments on FluoGuide’s Q3 2025 report. The company has posted a busy news flow in recent mon...
Redsense Medical fortsätter att växa trots valutamotvind, med en stark Q3-förbättring både i omsättn...
* Strategic pivot into the SOFC market * Rights issue of ~SEK 87.
Top Picks comments on a significant development that fundamentally changes one of our investment the...
Redeye provides a research update following the recently published Q3 report from Lipum.
Redeye returns with an updated view of Egetis Therapeutics following the Q3 report and the recent Re...
* European Commission drafts proposal for non-renewal of Selektope * Limited impact on near-term est...
European Commission draft, suggests a non-renewal for Selektope under EU BPR, which now seems as the...
Redeye updates its estimates and fair value range following Xplora’s Q3 report, which surprised posi...
Redeye visited Cheffelo’s Mölnlycke facility, where Linas Matkasse’s meal kits are produced.
